SUGAMMADEX SODIUM

SUGAMMADEX SODIUM was reported 1324 times

SUGAMMADEX SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEGATIVE PRESSURE PULMONARY OEDEMA 38 0.3878
1 OCCIPITOCERVICAL FUSION 1 0.3333
2 RECURRENCE OF NEUROMUSCULAR BLOCKADE 40 0.2339
3 NEUROMUSCULAR BLOCKADE REVERSAL 1 0.2000
4 CRICOPHARYNGEAL ACHALASIA 1 0.2000
5 ANAESTHESIA REVERSAL 1 0.1667
6 TIDAL VOLUME DECREASED 3 0.0769
7 MINI-TRACHEOSTOMY 1 0.0714
8 NEUROMUSCULAR BLOCK PROLONGED 24 0.0650
9 INTERSTITIAL LUNG THICKENING 1 0.0625
10 MAST CELL DEGRANULATION PRESENT 1 0.0526
11 POSTOPERATIVE HYPERTENSION 1 0.0500
12 SUBCAPSULAR SPLENIC HAEMATOMA 2 0.0444
13 BRONCHIAL ANASTOMOSIS COMPLICATION 1 0.0417
14 PARATONIA 1 0.0385
15 ENDOCARDIAL DISEASE 1 0.0345
16 VOCAL CORD DYSFUNCTION 17 0.0345
17 ANAESTHETIC COMPLICATION PULMONARY 3 0.0337
18 AIRWAY PEAK PRESSURE INCREASED 5 0.0329
19 CHEST WALL RIGIDITY 2 0.0312
20 PSEUDOCHOLINESTERASE DEFICIENCY 2 0.0308
21 CHANTER SYNDROME 3 0.0300
22 UNADJUSTED DOSE ADMINISTERED 2 0.0294
23 CENTRAL VENOUS PRESSURE DECREASED 1 0.0286
24 DELAYED RECOVERY FROM ANAESTHESIA 26 0.0274
25 NEUROMUSCULAR BLOCKADE 6 0.0268
26 SPLENIC VEIN OCCLUSION 1 0.0263
27 URINARY TRACT PROCEDURAL COMPLICATION 1 0.0263
28 PERIPARTUM HAEMORRHAGE 1 0.0244
29 PERINEAL NECROSIS 1 0.0244
30 HYPOSTHENURIA 1 0.0244
31 POSTOPERATIVE DELIRIUM 4 0.0202
32 POSTOPERATIVE RESPIRATORY FAILURE 2 0.0192
33 VASCULAR ACCESS MALFUNCTION 1 0.0185
34 CAROTID PULSE ABNORMAL 1 0.0185
35 SCROTAL CELLULITIS 1 0.0175
36 CORTICOBASAL DEGENERATION 1 0.0172
37 AGITATION POSTOPERATIVE 1 0.0159
38 POSTOPERATIVE RESPIRATORY DISTRESS 1 0.0156
39 CAPILLARY PERMEABILITY INCREASED 1 0.0154
40 ANAESTHETIC COMPLICATION CARDIAC 1 0.0145
41 NEONATAL RESPIRATORY ARREST 2 0.0137
42 MECHANICAL VENTILATION COMPLICATION 2 0.0134
43 PAROXYSMAL SYMPATHETIC HYPERACTIVITY 1 0.0133
44 AUTOPHONY 1 0.0133
45 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 1 0.0125
46 PERIHEPATIC ABSCESS 1 0.0120
47 LUNG PERFORATION 4 0.0119
48 MITOCHONDRIAL DNA MUTATION 1 0.0116
49 LARYNGOSPASM 31 0.0115
50 AIRWAY COMPLICATION OF ANAESTHESIA 3 0.0114
51 FOETAL HEART RATE INCREASED 1 0.0114
52 REYE'S SYNDROME 1 0.0111
53 ANAESTHETIC COMPLICATION NEUROLOGICAL 10 0.0110
54 PSYCHOGENIC SEIZURE 10 0.0107
55 SCROTAL ABSCESS 4 0.0106
56 DEAFNESS PERMANENT 2 0.0102
57 LICE INFESTATION 2 0.0095
58 EAR DRYNESS 1 0.0095
59 RESPIRATORY TRACT OEDEMA 7 0.0094
60 PINGUECULA 1 0.0094
61 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 1 0.0089
62 CIRCUMORAL OEDEMA 3 0.0086
63 FANCONI SYNDROME 12 0.0085
64 INCISION SITE INFLAMMATION 1 0.0085
65 PERIPHERAL VEIN OCCLUSION 1 0.0084
66 VASCULAR ACCESS SITE PAIN 1 0.0083
67 RADIAL PULSE ABNORMAL 1 0.0083
68 INCARCERATED INGUINAL HERNIA 1 0.0082
69 BRACHIOCEPHALIC VEIN THROMBOSIS 1 0.0081
70 HYPERTHERMIA MALIGNANT 12 0.0081
71 MEAN ARTERIAL PRESSURE DECREASED 2 0.0079
72 UPPER AIRWAY OBSTRUCTION 7 0.0079
73 UTERINE HAEMATOMA 1 0.0079
74 MAGNETIC RESONANCE IMAGING 1 0.0078
75 VASCULAR RESISTANCE SYSTEMIC DECREASED 1 0.0075
76 VENTRICULAR FLUTTER 1 0.0075
77 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 8 0.0073
78 VACTERL SYNDROME 1 0.0071
79 SUPRAVENTRICULAR TACHYARRHYTHMIA 1 0.0071
80 MATERNAL EXPOSURE DURING DELIVERY 7 0.0071
81 PARALYSIS RECURRENT LARYNGEAL NERVE 1 0.0068
82 PERINEAL ABSCESS 3 0.0067
83 THERAPEUTIC PRODUCT EFFECT PROLONGED 3 0.0066
84 ANTICHOLINERGIC SYNDROME 10 0.0063
85 RESPIRATORY PARALYSIS 1 0.0063
86 BLADDER CYST 1 0.0062
87 KOUNIS SYNDROME 14 0.0062
88 DYSCHROMATOPSIA 5 0.0060
89 SCROTAL ERYTHEMA 1 0.0060
90 PNEUMOBILIA 1 0.0060
91 CLONUS 16 0.0058
92 HYPOVENTILATION 19 0.0058
93 ACUTE CARDIAC EVENT 1 0.0058
94 SUBCHORIONIC HAEMATOMA 1 0.0057
95 APALLIC SYNDROME 4 0.0055
96 ENDOTRACHEAL INTUBATION COMPLICATION 3 0.0051
97 STENT MALFUNCTION 1 0.0051
98 EOSINOPHIL PERCENTAGE DECREASED 1 0.0050
99 DIAPHRAGMATIC PARALYSIS 3 0.0050
100 GENITAL ABSCESS 2 0.0050
101 POLYDIPSIA PSYCHOGENIC 1 0.0049
102 HYPERREFLEXIA 17 0.0049
103 BRADYCARDIA FOETAL 4 0.0048
104 PROCEDURAL HYPOTENSION 4 0.0047
105 MUSCLE OEDEMA 1 0.0046
106 PRODUCT CONTAMINATION CHEMICAL 1 0.0046
107 PROTHROMBIN TIME RATIO INCREASED 1 0.0046
108 PHRENIC NERVE PARALYSIS 1 0.0046
109 VERY LOW DENSITY LIPOPROTEIN INCREASED 1 0.0045
110 INFUSION SITE PHLEBITIS 1 0.0044
111 NECROTISING SOFT TISSUE INFECTION 1 0.0043
112 ORAL CONTUSION 1 0.0043
113 HYPOGONADISM MALE 1 0.0043
114 ANAPHYLACTOID SHOCK 2 0.0043
115 OVARIAN HAEMORRHAGE 1 0.0042
116 TRYPTASE INCREASED 3 0.0042
117 ENTEROBACTER TEST POSITIVE 1 0.0041
118 NEONATAL SEIZURE 1 0.0040
119 INCISION SITE DISCHARGE 1 0.0040
120 CYTOTOXIC OEDEMA 1 0.0038
121 PRIAPISM 13 0.0038
122 UTERINE CONTRACTIONS ABNORMAL 1 0.0037
123 VAGINAL ABSCESS 1 0.0037
124 BRADYARRHYTHMIA 6 0.0036
125 BRONCHOSPASM 52 0.0036
126 WRONG PRODUCT STORED 1 0.0035
127 EUSTACHIAN TUBE DYSFUNCTION 2 0.0035
128 EOSINOPHILIC PNEUMONIA ACUTE 3 0.0035
129 THERAPEUTIC PRODUCT EFFECT INCREASED 4 0.0034
130 DOSE CALCULATION ERROR 2 0.0034
131 CARDIAC PROCEDURE COMPLICATION 2 0.0033
132 CARBON DIOXIDE ABNORMAL 1 0.0032
133 WOUND INFECTION PSEUDOMONAS 1 0.0032
134 STOMA SITE HYPERGRANULATION 2 0.0032
135 CYANOSIS NEONATAL 2 0.0031
136 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL 1 0.0031
137 EXTRAOCULAR MUSCLE DISORDER 1 0.0031
138 PROCEDURAL VOMITING 2 0.0031
139 COAGULATION TIME SHORTENED 1 0.0030
140 ADMINISTRATION SITE EXTRAVASATION 3 0.0030
141 HYPERCAPNIA 9 0.0030
142 ANAPHYLACTIC REACTION 165 0.0030
143 CUBITAL TUNNEL SYNDROME 1 0.0029
144 CUTANEOUS SYMPTOM 2 0.0029
145 ANAPHYLACTIC SHOCK 75 0.0029
146 CHOREA 5 0.0029
147 CONSCIOUSNESS FLUCTUATING 3 0.0029
148 MUSCLE HYPERTROPHY 1 0.0028
149 MAST CELL ACTIVATION SYNDROME 4 0.0028
150 RESPIRATORY ACIDOSIS 11 0.0028
151 OCULOGYRIC CRISIS 6 0.0028
152 CEREBRAL MASS EFFECT 1 0.0028
153 HAEMODYNAMIC INSTABILITY 21 0.0028
154 CANCER PAIN 7 0.0027
155 PERIRECTAL ABSCESS 3 0.0027
156 BRAIN STEM SYNDROME 2 0.0027
157 NASAL TURBINATE HYPERTROPHY 1 0.0027
158 ANISOCORIA 1 0.0026
159 PULSELESS ELECTRICAL ACTIVITY 11 0.0026
160 BREATH HOLDING 1 0.0026
161 INTRACRANIAL TUMOUR HAEMORRHAGE 1 0.0026
162 GASTROINTESTINAL ANASTOMOTIC LEAK 1 0.0026
163 SINUS ARREST 4 0.0025
164 HAEMOPERITONEUM 2 0.0025
165 ELECTROCARDIOGRAM T WAVE PEAKED 1 0.0025
166 LYMPHOCYTE PERCENTAGE INCREASED 1 0.0025
167 USE OF ACCESSORY RESPIRATORY MUSCLES 1 0.0024
168 FRONTOTEMPORAL DEMENTIA 1 0.0023
169 LANGUAGE DISORDER 5 0.0023
170 ENDOCRINE OPHTHALMOPATHY 2 0.0023
171 FANCONI SYNDROME ACQUIRED 4 0.0023
172 CONGENITAL MUSCULOSKELETAL ANOMALY 1 0.0023
173 SPINAL CORD INFARCTION 1 0.0023
174 IMPLANT SITE HAEMORRHAGE 1 0.0023
175 VOCAL CORD PARALYSIS 4 0.0022
176 POSTPARTUM HAEMORRHAGE 3 0.0022
177 HEAD TITUBATION 3 0.0022
178 LOCKED-IN SYNDROME 1 0.0022
179 CEREBRAL HYPOPERFUSION 1 0.0021
180 NEONATAL RESPIRATORY DISTRESS 2 0.0021
181 STATUS ASTHMATICUS 1 0.0021
182 OPEN FRACTURE 1 0.0021
183 ADRENOCORTICAL INSUFFICIENCY ACUTE 4 0.0020
184 STRIDOR 6 0.0020
185 RETROGRADE AMNESIA 1 0.0020
186 TRACHEAL STENOSIS 1 0.0020
187 STOMA SITE HAEMORRHAGE 3 0.0019
188 BRUGADA SYNDROME 2 0.0019
189 COGWHEEL RIGIDITY 2 0.0019
190 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 2 0.0019
191 ASTERIXIS 2 0.0019
192 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
193 ANAL ATRESIA 1 0.0019
194 HEART FAILURE WITH REDUCED EJECTION FRACTION 1 0.0019
195 TACHYPNOEA 25 0.0018
196 BRONCHOSTENOSIS 1 0.0018
197 MACROGLOSSIA 1 0.0018
198 DRUG EFFECT PROLONGED 1 0.0018
199 PRESBYOPIA 1 0.0018
200 NEUROLOGIC NEGLECT SYNDROME 1 0.0018
201 BONE FRAGMENTATION 1 0.0018
202 PULMONARY ALVEOLAR HAEMORRHAGE 10 0.0018
203 GAZE PALSY 3 0.0018
204 PAROTITIS 2 0.0017
205 NERVE BLOCK 1 0.0017
206 GROIN ABSCESS 2 0.0017
207 HYPERTENSIVE ENCEPHALOPATHY 1 0.0017
208 FAT NECROSIS 1 0.0016
209 PUPILLARY DISORDER 1 0.0016
210 PARADOXICAL DRUG REACTION 6 0.0016
211 BRADYCARDIA 85 0.0016
212 DERMATOSIS 1 0.0016
213 HYPERAESTHESIA 13 0.0016
214 EXTREMITY CONTRACTURE 1 0.0016
215 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 4 0.0015
216 SPUTUM ABNORMAL 1 0.0015
217 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1 0.0015
218 CATARACT NUCLEAR 1 0.0015
219 BRADYPNOEA 4 0.0015
220 PULSE ABSENT 7 0.0015
221 RENAL APLASIA 1 0.0014
222 TONGUE PARALYSIS 1 0.0014
223 PCO2 INCREASED 1 0.0014
224 DISSOCIATIVE DISORDER 1 0.0014
225 PERIODONTITIS 3 0.0014
226 INFANTILE SPASMS 1 0.0014
227 CEREBELLAR SYNDROME 3 0.0014
228 MYASTHENIA GRAVIS CRISIS 2 0.0013
229 LYMPH NODE TUBERCULOSIS 1 0.0013
230 BRAIN HERNIATION 4 0.0013
231 PERFORATED ULCER 1 0.0013
232 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 8 0.0013
233 MYASTHENIC SYNDROME 1 0.0013
234 BREAST FEEDING 1 0.0013
235 HYPOTONIA NEONATAL 2 0.0013
236 PROCEDURAL NAUSEA 1 0.0012
237 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
238 MEDICAL PROCEDURE 2 0.0012
239 TACHYARRHYTHMIA 3 0.0012
240 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
241 NODAL ARRHYTHMIA 1 0.0012
242 POST-INJECTION DELIRIUM SEDATION SYNDROME 1 0.0012
243 APNOEA 9 0.0012
244 COMPARTMENT SYNDROME 3 0.0011
245 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 1 0.0011
246 HYPOXIA 40 0.0011
247 LARYNGEAL OEDEMA 7 0.0011
248 THERAPEUTIC PRODUCT CROSS-REACTIVITY 1 0.0011
249 ANAESTHETIC COMPLICATION 3 0.0011
250 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
251 CERUMEN IMPACTION 1 0.0011
252 SKIN TEST POSITIVE 1 0.0011
253 HEPATIC CONGESTION 1 0.0011
254 RESPIRATORY SYMPTOM 3 0.0011
255 ARNOLD-CHIARI MALFORMATION 1 0.0010
256 ATRIOVENTRICULAR BLOCK COMPLETE 7 0.0010
257 WRONG PRODUCT ADMINISTERED 7 0.0010
258 COMA SCALE ABNORMAL 3 0.0010
259 STRESS CARDIOMYOPATHY 6 0.0010
260 ABDOMINAL WALL HAEMATOMA 2 0.0010
261 SUBCUTANEOUS EMPHYSEMA 1 0.0010
262 VOCAL CORD DISORDER 2 0.0010
263 BLOOD ALBUMIN DECREASED 8 0.0010
264 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
265 MUSCLE RIGIDITY 12 0.0010
266 PROTHROMBIN TIME PROLONGED 6 0.0010
267 BRAIN HYPOXIA 1 0.0010
268 SEROTONIN SYNDROME 19 0.0010
269 TOXIC ENCEPHALOPATHY 5 0.0010
270 MATERNAL EXPOSURE DURING BREAST FEEDING 4 0.0010
271 UTERINE PAIN 1 0.0010
272 CONJUNCTIVAL OEDEMA 1 0.0010
273 UTERINE CONTRACTIONS DURING PREGNANCY 1 0.0010
274 FACTOR VIII INHIBITION 1 0.0010
275 BONE DEMINERALISATION 1 0.0009
276 POST PROCEDURAL HAEMORRHAGE 11 0.0009
277 HYPERTENSIVE NEPHROPATHY 1 0.0009
278 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
279 SINUS BRADYCARDIA 9 0.0009
280 ORCHITIS 1 0.0009
281 EXPOSED BONE IN JAW 2 0.0009
282 PRODUCT SELECTION ERROR 1 0.0009
283 DEAFNESS NEUROSENSORY 3 0.0009
284 MUSCLE TWITCHING 21 0.0009
285 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
286 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 3 0.0009
287 NEPHROSCLEROSIS 1 0.0009
288 CRYPTORCHISM 1 0.0009
289 IDIOPATHIC INTRACRANIAL HYPERTENSION 2 0.0009
290 CARDIAC ARREST 72 0.0009
291 TYPE I HYPERSENSITIVITY 3 0.0009
292 INCISION SITE PAIN 1 0.0009
293 NECROTISING FASCIITIS 3 0.0009
294 LABILE BLOOD PRESSURE 1 0.0008
295 NEUTROPENIC SEPSIS 6 0.0008
296 HAEMATOMA MUSCLE 1 0.0008
297 BODY TEMPERATURE INCREASED 17 0.0008
298 CARDIOMYOPATHY 12 0.0008
299 MALIGNANT MELANOMA IN SITU 1 0.0008
300 HYPOTONIA 8 0.0008
301 HYPERPARATHYROIDISM SECONDARY 2 0.0008
302 BRONCHIAL SECRETION RETENTION 1 0.0008
303 SUBCUTANEOUS HAEMATOMA 1 0.0008
304 ATRIOVENTRICULAR BLOCK 6 0.0008
305 BILIARY OBSTRUCTION 1 0.0008
306 PARALYSIS 11 0.0008
307 SINUS ARRHYTHMIA 1 0.0008
308 POSTMENOPAUSAL HAEMORRHAGE 2 0.0008
309 LOW BIRTH WEIGHT BABY 6 0.0008
310 BLOOD POTASSIUM ABNORMAL 2 0.0007
311 HYPERLACTACIDAEMIA 2 0.0007
312 RESPIRATORY DEPRESSION 9 0.0007
313 HYDROCEPHALUS 4 0.0007
314 ANAPHYLACTOID REACTION 3 0.0007
315 VENTRICULAR FIBRILLATION 8 0.0007
316 LUNG CONSOLIDATION 2 0.0007
317 ENDOTRACHEAL INTUBATION 2 0.0007
318 BRONCHIAL OBSTRUCTION 1 0.0007
319 TONIC CONVULSION 1 0.0007
320 AUDITORY DISORDER 1 0.0007
321 UTERINE HAEMORRHAGE 3 0.0007
322 ABSCESS LIMB 3 0.0007
323 PALLOR 19 0.0007
324 PELVIC VENOUS THROMBOSIS 1 0.0007
325 PRODUCT MONITORING ERROR 1 0.0007
326 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
327 PULMONARY SEPSIS 1 0.0007
328 PULMONARY VALVE INCOMPETENCE 1 0.0007
329 NODAL RHYTHM 1 0.0007
330 STRABISMUS 2 0.0007
331 PHYSICAL DISABILITY 3 0.0007
332 OXYGEN SATURATION DECREASED 38 0.0007
333 APRAXIA 1 0.0007
334 RASH MACULO-PAPULAR 15 0.0007
335 SECONDARY ADRENOCORTICAL INSUFFICIENCY 1 0.0007
336 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
337 BLOOD PRESSURE IMMEASURABLE 1 0.0007
338 MEAN CELL VOLUME DECREASED 1 0.0006
339 NEPHROGENIC ANAEMIA 3 0.0006
340 BRAIN DEATH 2 0.0006
341 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
342 RESPIRATORY RATE DECREASED 2 0.0006
343 SKIN ABRASION 3 0.0006
344 INHIBITORY DRUG INTERACTION 1 0.0006
345 SCREAMING 4 0.0006
346 VENTRICULAR HYPOKINESIA 2 0.0006
347 LIVER ABSCESS 2 0.0006
348 SHOCK HAEMORRHAGIC 5 0.0006
349 SHOULDER FRACTURE 1 0.0006
350 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
351 BRAIN INJURY 6 0.0006
352 RECTAL ABSCESS 1 0.0006
353 POST PROCEDURAL HAEMATOMA 1 0.0006
354 BLOOD PH DECREASED 1 0.0006
355 PUPIL FIXED 1 0.0006
356 HYPOPNOEA 2 0.0006
357 PSEUDOMONAL SEPSIS 1 0.0006
358 SKIN REACTION 8 0.0006
359 IMPRISONMENT 1 0.0006
360 PANCREATIC FAILURE 1 0.0006
361 MITRAL VALVE DISEASE 1 0.0006
362 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
363 AORTIC VALVE STENOSIS 1 0.0006
364 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
365 ANAL ABSCESS 3 0.0006
366 UTERINE SPASM 1 0.0005
367 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
368 STENOSIS 1 0.0005
369 GUN SHOT WOUND 1 0.0005
370 HYPOPROTEINAEMIA 1 0.0005
371 PROCEDURAL COMPLICATION 4 0.0005
372 RALES 3 0.0005
373 CONVERSION DISORDER 1 0.0005
374 EARLY SATIETY 1 0.0005
375 NASAL SEPTUM DEVIATION 1 0.0005
376 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
377 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
378 ARTERIOSPASM CORONARY 2 0.0005
379 ANGIOEDEMA 22 0.0005
380 RESPIRATORY FAILURE 36 0.0005
381 MUSCLE CONTRACTURE 1 0.0005
382 VASCULAR STENT THROMBOSIS 1 0.0005
383 DIVERTICULAR PERFORATION 1 0.0005
384 FOETAL DISTRESS SYNDROME 1 0.0005
385 RENAL NEOPLASM 1 0.0005
386 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
387 CIRCULATORY COLLAPSE 8 0.0005
388 DYSKINESIA 19 0.0005
389 ABSCESS INTESTINAL 1 0.0005
390 INFUSION SITE BRUISING 1 0.0005
391 SPUTUM INCREASED 1 0.0005
392 PARESIS 1 0.0004
393 ADENOCARCINOMA 1 0.0004
394 RESPIRATION ABNORMAL 3 0.0004
395 DRUG INTERACTION 69 0.0004
396 EYELID DISORDER 1 0.0004
397 HAEMANGIOMA 1 0.0004
398 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
399 DIABETES INSIPIDUS 1 0.0004
400 PRODUCT PACKAGING CONFUSION 1 0.0004
401 TACHYCARDIA 36 0.0004
402 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
403 RESPIRATORY ARREST 11 0.0004
404 RESPIRATORY DISTRESS 11 0.0004
405 ANGLE CLOSURE GLAUCOMA 1 0.0004
406 SEDATION COMPLICATION 1 0.0004
407 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 2 0.0004
408 MEAN CELL VOLUME INCREASED 1 0.0004
409 HYPOTENSION 78 0.0004
410 UNRESPONSIVE TO STIMULI 10 0.0004
411 CATATONIA 2 0.0004
412 LUNG OPACITY 1 0.0004
413 PREMATURE DELIVERY 6 0.0004
414 NASAL DISORDER 1 0.0004
415 BREAST SWELLING 1 0.0004
416 ABDOMINAL RIGIDITY 1 0.0004
417 POLYURIA 3 0.0004
418 MUSCLE INJURY 3 0.0004
419 CHOLECYSTITIS INFECTIVE 1 0.0004
420 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
421 DRUG TOLERANCE DECREASED 1 0.0004
422 PERIORBITAL SWELLING 2 0.0004
423 OXYGEN SATURATION ABNORMAL 1 0.0004
424 PARAESTHESIA ORAL 5 0.0003
425 PARAPLEGIA 1 0.0003
426 ADENOVIRUS INFECTION 1 0.0003
427 PRODUCT LABEL CONFUSION 2 0.0003
428 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
429 HYPOVOLAEMIA 2 0.0003
430 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
431 MYOCLONUS 4 0.0003
432 URINE ANALYSIS ABNORMAL 1 0.0003
433 METABOLIC ENCEPHALOPATHY 1 0.0003
434 ECONOMIC PROBLEM 5 0.0003
435 FOETAL GROWTH RESTRICTION 2 0.0003
436 ENCEPHALOPATHY 8 0.0003
437 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
438 BLOOD CREATININE DECREASED 1 0.0003
439 BLADDER PAIN 1 0.0003
440 RASH PRURITIC 17 0.0003
441 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
442 POST PROCEDURAL COMPLICATION 6 0.0003
443 STUPOR 1 0.0003
444 NEAR DEATH EXPERIENCE 1 0.0003
445 PEPTIC ULCER 1 0.0003
446 POTENTIATING DRUG INTERACTION 1 0.0003
447 WOUND DEHISCENCE 1 0.0003
448 WOUND COMPLICATION 1 0.0003
449 MICTURITION DISORDER 1 0.0003
450 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
451 NEONATAL RESPIRATORY DISTRESS SYNDROME 1 0.0003
452 FACIAL PARESIS 1 0.0003
453 FIBRIN D DIMER INCREASED 1 0.0003
454 PRODUCT CONTAMINATION 1 0.0003
455 CONJUNCTIVAL HYPERAEMIA 1 0.0003
456 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
457 FACIAL BONES FRACTURE 1 0.0003
458 MONOCYTE COUNT INCREASED 1 0.0003
459 VENTRICULAR ARRHYTHMIA 1 0.0003
460 FOOD INTOLERANCE 1 0.0003
461 THROMBOCYTOSIS 1 0.0003
462 BLINDNESS TRANSIENT 2 0.0003
463 HYPERTENSIVE CRISIS 3 0.0003
464 CARDIAC DYSFUNCTION 1 0.0003
465 MUCOSAL INFLAMMATION 7 0.0003
466 CHRONIC SINUSITIS 1 0.0003
467 AUTOIMMUNE THYROIDITIS 1 0.0003
468 SNORING 1 0.0003
469 TONGUE OEDEMA 1 0.0003
470 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
471 ACUTE RESPIRATORY FAILURE 5 0.0003
472 DYSTONIA 5 0.0003
473 EPIGASTRIC DISCOMFORT 1 0.0003
474 PULMONARY HAEMORRHAGE 2 0.0003
475 PNEUMOTHORAX 4 0.0003
476 PATENT DUCTUS ARTERIOSUS 1 0.0003
477 CHOLECYSTITIS 3 0.0003
478 WOUND 7 0.0003
479 METABOLIC ACIDOSIS 8 0.0002
480 CYSTITIS HAEMORRHAGIC 1 0.0002
481 DEMYELINATION 1 0.0002
482 ARTHRITIS BACTERIAL 1 0.0002
483 SELF-MEDICATION 1 0.0002
484 EXTRAVASATION 1 0.0002
485 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
486 AORTIC DISSECTION 1 0.0002
487 ACUTE CORONARY SYNDROME 2 0.0002
488 EOSINOPHIL COUNT INCREASED 2 0.0002
489 BRAIN OEDEMA 3 0.0002
490 MUSCLE FATIGUE 1 0.0002
491 HEPATITIS 6 0.0002
492 PURULENT DISCHARGE 1 0.0002
493 MYDRIASIS 3 0.0002
494 PREMATURE BABY 7 0.0002
495 HAEMATOMA 6 0.0002
496 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
497 TUMOUR LYSIS SYNDROME 2 0.0002
498 ABDOMINAL ABSCESS 1 0.0002
499 ILEUS PARALYTIC 1 0.0002
500 MENINGITIS ASEPTIC 1 0.0002
501 DRUG EFFECT DELAYED 1 0.0002
502 C-REACTIVE PROTEIN INCREASED 8 0.0002
503 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
504 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
505 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
506 EYE OPERATION 1 0.0002
507 UROSEPSIS 2 0.0002
508 CARDIO-RESPIRATORY ARREST 9 0.0002
509 TIBIA FRACTURE 1 0.0002
510 MATERNAL EXPOSURE DURING PREGNANCY 19 0.0002
511 SINUS TACHYCARDIA 3 0.0002
512 SPUTUM DISCOLOURED 2 0.0002
513 HYPOVOLAEMIC SHOCK 1 0.0002
514 SUBCUTANEOUS ABSCESS 1 0.0002
515 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
516 INCORRECT DOSAGE ADMINISTERED 1 0.0002
517 BODY TEMPERATURE DECREASED 2 0.0002
518 BREATH SOUNDS ABNORMAL 1 0.0002
519 DISABILITY 4 0.0002
520 OVARIAN CYST 2 0.0002
521 HYPOAESTHESIA ORAL 3 0.0002
522 CORONARY ARTERY STENOSIS 1 0.0002
523 HYPOTHERMIA 2 0.0002
524 MOTOR DYSFUNCTION 2 0.0002
525 TRISMUS 1 0.0002
526 FOETAL DEATH 1 0.0002
527 PERIORBITAL OEDEMA 1 0.0002
528 VENTRICULAR EXTRASYSTOLES 2 0.0002
529 TONSILLITIS 1 0.0002
530 PARTIAL SEIZURES 1 0.0002
531 CYANOSIS 3 0.0002
532 NYSTAGMUS 1 0.0002
533 ANAL FISTULA 1 0.0002
534 BRUXISM 1 0.0002
535 ERYTHEMA OF EYELID 1 0.0002
536 NORMAL NEWBORN 1 0.0002
537 ASPIRATION 2 0.0002
538 VENTRICULAR TACHYCARDIA 3 0.0002
539 COAGULOPATHY 3 0.0002
540 PULMONARY OEDEMA 8 0.0002
541 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
542 ACUTE PULMONARY OEDEMA 1 0.0002
543 AGITATION 13 0.0002
544 CHOLECYSTITIS ACUTE 1 0.0002
545 NEUTROPHILIA 1 0.0002
546 DELIRIUM 6 0.0002
547 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
548 HEART RATE DECREASED 6 0.0002
549 BRADYKINESIA 1 0.0002
550 WHEEZING 10 0.0002
551 BACTERAEMIA 2 0.0002
552 RESPIRATORY DISORDER 5 0.0002
553 LEUKOCYTOSIS 3 0.0002
554 END STAGE RENAL DISEASE 3 0.0002
555 INGUINAL HERNIA 1 0.0002
556 CHOLANGITIS 1 0.0002
557 EXTRAPYRAMIDAL DISORDER 4 0.0002
558 INFUSION SITE EXTRAVASATION 1 0.0002
559 SWELLING OF EYELID 1 0.0002
560 BLEPHAROSPASM 1 0.0002
561 DRUG RESISTANCE 4 0.0002
562 URTICARIA 26 0.0002
563 CARDIAC FAILURE ACUTE 1 0.0001
564 CYTOKINE RELEASE SYNDROME 3 0.0001
565 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
566 POST-TRAUMATIC STRESS DISORDER 1 0.0001
567 QUALITY OF LIFE DECREASED 2 0.0001
568 PRODUCT LABEL ISSUE 1 0.0001
569 EYE MOVEMENT DISORDER 1 0.0001
570 ECCHYMOSIS 1 0.0001
571 AUTOIMMUNE HEPATITIS 1 0.0001
572 EXTRASYSTOLES 1 0.0001
573 RIGHT VENTRICULAR FAILURE 1 0.0001
574 HALLUCINATION, VISUAL 3 0.0001
575 PAPULE 1 0.0001
576 LIVER FUNCTION TEST INCREASED 3 0.0001
577 IMPAIRED QUALITY OF LIFE 2 0.0001
578 GRAFT VERSUS HOST DISEASE 1 0.0001
579 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
580 PANIC REACTION 1 0.0001
581 SEPTIC SHOCK 6 0.0001
582 INTENTIONAL PRODUCT USE ISSUE 12 0.0001
583 BONE PAIN 8 0.0001
584 HYPOPHOSPHATAEMIA 1 0.0001
585 HYDRONEPHROSIS 1 0.0001
586 THERAPY NON-RESPONDER 6 0.0001
587 HYPERTHERMIA 1 0.0001
588 ACIDOSIS 1 0.0001
589 SHOCK 3 0.0001
590 EXPOSURE DURING PREGNANCY 8 0.0001
591 HYPOALBUMINAEMIA 1 0.0001
592 SWOLLEN TONGUE 4 0.0001
593 AFFECTIVE DISORDER 1 0.0001
594 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
595 TRICUSPID VALVE INCOMPETENCE 1 0.0001
596 ABSCESS 2 0.0001
597 SENSORY LOSS 1 0.0001
598 MYASTHENIA GRAVIS 1 0.0001
599 FRUSTRATION TOLERANCE DECREASED 1 0.0001
600 MUSCULAR WEAKNESS 14 0.0001
601 BLOOD POTASSIUM INCREASED 2 0.0001
602 SWELLING FACE 8 0.0001
603 HICCUPS 1 0.0001
604 OSTEONECROSIS OF JAW 3 0.0001
605 PARAESTHESIA 19 0.0001
606 HAEMODIALYSIS 1 0.0001
607 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
608 FACIAL PARALYSIS 1 0.0001
609 VITAMIN D DECREASED 1 0.0001
610 SPEECH DISORDER 6 0.0001
611 URINE OUTPUT DECREASED 1 0.0001
612 HYPERTENSION 24 0.0001
613 LUNG INFILTRATION 1 0.0001
614 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
615 MYOSITIS 1 0.0001
616 CONFUSIONAL STATE 18 0.0001
617 DEVELOPMENTAL DELAY 1 0.0001
618 CRYING 4 0.0001
619 HYPERGLYCAEMIA 4 0.0001
620 ACCIDENTAL OVERDOSE 4 0.0001
621 RETINAL DETACHMENT 1 0.0001
622 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
623 MENTAL STATUS CHANGES 3 0.0001
624 HAEMOPTYSIS 3 0.0001
625 HEPATIC FUNCTION ABNORMAL 4 0.0001
626 HEPATIC ENCEPHALOPATHY 1 0.0001
627 APPENDICITIS 1 0.0001
628 FLANK PAIN 1 0.0001
629 BLOOD PRESSURE DECREASED 7 0.0001
630 RECALLED PRODUCT ADMINISTERED 1 0.0001
631 EYE INFLAMMATION 1 0.0001
632 SEIZURE 12 0.0001
633 ATELECTASIS 1 0.0001
634 THROMBOTIC MICROANGIOPATHY 1 0.0001
635 PARKINSONISM 1 0.0001
636 CHOKING 2 0.0001
637 PHARYNGEAL SWELLING 1 0.0001
638 ASCITES 3 0.0001
639 RENAL TUBULAR NECROSIS 1 0.0001
640 LOSS OF CONSCIOUSNESS 13 0.0001
641 URINARY INCONTINENCE 3 0.0001
642 SALIVARY HYPERSECRETION 1 0.0001
643 HEPATIC FAILURE 3 0.0001
644 PLEURAL EFFUSION 6 0.0001
645 TOOTH ABSCESS 1 0.0001
646 EAR DISCOMFORT 1 0.0001
647 TENDERNESS 1 0.0001
648 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
649 BREAST PAIN 1 0.0001
650 EPISTAXIS 7 0.0001
651 OEDEMA 5 0.0001
652 CHRONIC KIDNEY DISEASE 7 0.0001
653 SKIN LACERATION 1 0.0001
654 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
655 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
656 LIP SWELLING 3 0.0001
657 NERVE INJURY 1 0.0001
658 URINARY RETENTION 3 0.0001
659 MALNUTRITION 1 0.0001
660 FISTULA 1 0.0001
661 STATUS EPILEPTICUS 1 0.0001
662 MITRAL VALVE INCOMPETENCE 1 0.0001
663 MYOCARDIAL ISCHAEMIA 1 0.0001
664 ERYTHEMA 18 0.0001
665 TINNITUS 4 0.0001
666 PERICARDIAL EFFUSION 2 0.0001
667 ELECTROLYTE IMBALANCE 1 0.0001
668 EYELID OEDEMA 1 0.0001
669 SPINAL PAIN 1 0.0001
670 PRODUCT USE IN UNAPPROVED INDICATION 21 0.0001
671 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
672 ATAXIA 1 0.0001
673 BLOOD PRESSURE FLUCTUATION 2 0.0001
674 DRUG EFFECT INCOMPLETE 3 0.0001
675 MENTAL IMPAIRMENT 2 0.0001
676 OEDEMA PERIPHERAL 10 0.0001
677 RESTLESSNESS 3 0.0001
678 LIVER INJURY 2 0.0001
679 CARDIOMEGALY 1 0.0001
680 SMALL INTESTINAL OBSTRUCTION 1 0.0001
681 SEPSIS 9 0.0001
682 PNEUMONIA ASPIRATION 2 0.0001
683 POISONING 1 0.0001
684 CELLULITIS 4 0.0001
685 HYPOPHAGIA 2 0.0001
686 HYPERHIDROSIS 10 0.0001
687 SEDATION 2 0.0001
688 BEDRIDDEN 1 0.0001
689 PULMONARY CONGESTION 1 0.0001
690 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
691 SOPOR 1 0.0001
692 FEBRILE NEUTROPENIA 5 0.0001
693 JOINT RANGE OF MOTION DECREASED 1 0.0001
694 BLINDNESS 3 0.0001
695 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
696 RHABDOMYOLYSIS 3 0.0001
697 ACUTE KIDNEY INJURY 11 0.0001
698 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
699 APHONIA 1 0.0001
700 PANCYTOPENIA 4 0.0001
701 INJURY 5 0.0001
702 PAIN IN JAW 2 0.0001
703 SUBDURAL HAEMATOMA 1 0.0001
704 RECTAL HAEMORRHAGE 3 0.0001
705 CARDIOGENIC SHOCK 1 0.0001
706 PANCREATIC CARCINOMA 2 0.0001
707 HYPERTHYROIDISM 1 0.0001
708 DYSPHONIA 4 0.0001
709 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
710 ACUTE MYOCARDIAL INFARCTION 2 0.0001
711 DRUG INEFFECTIVE 89 0.0001
712 PULMONARY MASS 1 0.0001
713 THERAPEUTIC RESPONSE DECREASED 4 0.0001
714 OSTEOPENIA 1 0.0001
715 PHARYNGEAL OEDEMA 1 0.0001
716 OROPHARYNGEAL PAIN 6 0.0001
717 ANKLE FRACTURE 1 0.0001
718 COGNITIVE DISORDER 3 0.0001
719 RASH 28 0.0001
720 THERAPY PARTIAL RESPONDER 1 0.0001
721 NERVOUS SYSTEM DISORDER 2 0.0001
722 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
723 OBESITY 1 0.0001
724 MOVEMENT DISORDER 2 0.0001
725 HIP FRACTURE 2 0.0001
726 MUSCLE TIGHTNESS 1 0.0001
727 ATRIAL FIBRILLATION 6 0.0001
728 MULTIPLE FRACTURES 1 0.0001
729 INFUSION RELATED REACTION 4 0.0001
730 OVERDOSE 13 0.0001
731 HEMIPARESIS 1 0.0001
732 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
733 HYPERKALAEMIA 2 0.0001
734 LYMPHOCYTE COUNT DECREASED 1 0.0001
735 CEREBRAL HAEMORRHAGE 2 0.0001
736 OSTEOMYELITIS 1 0.0001
737 HYPERSENSITIVITY 10 0.0001
738 AGRANULOCYTOSIS 1 0.0001
739 HEPATIC STEATOSIS 1 0.0001
740 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
741 EYE PAIN 3 0.0001
742 HYPOCALCAEMIA 1 0.0001
743 FOOT FRACTURE 1 0.0001
744 DYSPHAGIA 5 0.0001
745 NEUROPATHY PERIPHERAL 5 0.0001
746 MUSCULOSKELETAL DISORDER 1 0.0001
747 SLEEP APNOEA SYNDROME 1 0.0001
748 BLOOD PRESSURE INCREASED 8 0.0001
749 HERNIA 1 0.0001
750 EAR PAIN 1 0.0001
751 BLOOD PRESSURE ABNORMAL 1 0.0001
752 DISCOMFORT 3 0.0000
753 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
754 PRODUCT USE ISSUE 9 0.0000
755 WITHDRAWAL SYNDROME 2 0.0000
756 IMPAIRED WORK ABILITY 1 0.0000
757 AMNESIA 3 0.0000
758 MENTAL DISORDER 2 0.0000
759 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
760 RENAL FAILURE 6 0.0000
761 TRANSAMINASES INCREASED 1 0.0000
762 RENAL DISORDER 2 0.0000
763 DISEASE PROGRESSION 5 0.0000
764 OCULAR HYPERAEMIA 2 0.0000
765 COMA 2 0.0000
766 RASH ERYTHEMATOUS 2 0.0000
767 EMOTIONAL DISTRESS 5 0.0000
768 UNDERDOSE 3 0.0000
769 CEREBRAL INFARCTION 1 0.0000
770 DYSPNOEA 23 0.0000
771 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
772 OFF LABEL USE 35 0.0000
773 AGGRESSION 2 0.0000
774 SOMNOLENCE 8 0.0000
775 GASTRIC CANCER 1 0.0000
776 HAEMATEMESIS 1 0.0000
777 ERECTILE DYSFUNCTION 1 0.0000
778 DIPLOPIA 1 0.0000
779 HAEMORRHAGE 4 0.0000
780 DEAFNESS 1 0.0000
781 ANHEDONIA 1 0.0000
782 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
783 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
784 JAUNDICE 1 0.0000
785 DRUG EFFECT DECREASED 2 0.0000
786 BLOOD BILIRUBIN INCREASED 1 0.0000
787 LIMB INJURY 1 0.0000
788 PRODUCT QUALITY ISSUE 5 0.0000
789 SKIN LESION 1 0.0000
790 RENAL IMPAIRMENT 3 0.0000
791 TOXICITY TO VARIOUS AGENTS 6 0.0000
792 ANXIETY 10 0.0000
793 LETHARGY 2 0.0000
794 BALANCE DISORDER 3 0.0000
795 PAIN IN EXTREMITY 10 0.0000
796 PRURITUS 13 0.0000
797 HYPOAESTHESIA 5 0.0000
798 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
799 EPILEPSY 1 0.0000
800 MALAISE 14 0.0000
801 MOOD SWINGS 1 0.0000
802 PNEUMONIA 10 0.0000
803 DEEP VEIN THROMBOSIS 2 0.0000
804 BLOOD CREATININE INCREASED 2 0.0000
805 OSTEONECROSIS 1 0.0000
806 TREMOR 5 0.0000
807 VISUAL ACUITY REDUCED 1 0.0000
808 VIRAL INFECTION 1 0.0000
809 CONDITION AGGRAVATED 9 0.0000
810 ANGER 1 0.0000
811 NEOPLASM PROGRESSION 1 0.0000
812 COUGH 8 0.0000
813 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
814 MOBILITY DECREASED 2 0.0000
815 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
816 EYE SWELLING 1 0.0000
817 THROMBOCYTOPENIA 3 0.0000
818 DYSARTHRIA 1 0.0000
819 ASTHMA 3 0.0000
820 HALLUCINATION 2 0.0000
821 BLOOD GLUCOSE INCREASED 5 0.0000
822 INTESTINAL OBSTRUCTION 1 0.0000
823 ARTHRALGIA 11 0.0000
824 COLITIS 1 0.0000
825 ANAEMIA 5 0.0000
826 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
827 DISORIENTATION 1 0.0000
828 CARDIAC FAILURE CONGESTIVE 2 0.0000
829 EXTRA DOSE ADMINISTERED 1 0.0000
830 OSTEOPOROSIS 1 0.0000
831 POLLAKIURIA 1 0.0000
832 OSTEOARTHRITIS 1 0.0000
833 RENAL FAILURE ACUTE 1 0.0000
834 MYALGIA 4 0.0000
835 URINARY TRACT INFECTION 4 0.0000
836 VOMITING 11 0.0000
837 VAGINAL HAEMORRHAGE 1 0.0000
838 CONSTIPATION 5 0.0000
839 INSOMNIA 6 0.0000
840 COLITIS ULCERATIVE 1 0.0000
841 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
842 MUSCLE SPASMS 4 0.0000
843 SKIN DISCOLOURATION 1 0.0000
844 HYPOKALAEMIA 1 0.0000
845 BLOOD CHOLESTEROL INCREASED 1 0.0000
846 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
847 ARRHYTHMIA 1 0.0000
848 DISEASE RECURRENCE 1 0.0000
849 BLOOD GLUCOSE DECREASED 1 0.0000
850 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
851 INFECTION 3 0.0000
852 HYPOGLYCAEMIA 1 0.0000
853 DYSPEPSIA 2 0.0000
854 HEART RATE INCREASED 2 0.0000
855 DRY EYE 1 0.0000
856 LEUKOPENIA 1 0.0000
857 FLUID RETENTION 1 0.0000
858 HAEMOGLOBIN DECREASED 2 0.0000
859 PERIPHERAL SWELLING 3 0.0000
860 INFLAMMATION 1 0.0000
861 PANCREATITIS 1 0.0000
862 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
863 TREATMENT NONCOMPLIANCE 1 0.0000
864 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
865 HAEMATOCHEZIA 1 0.0000
866 MEDICATION ERROR 1 0.0000
867 HYPONATRAEMIA 1 0.0000
868 FLATULENCE 1 0.0000
869 INCORRECT DOSE ADMINISTERED 4 0.0000
870 CONVULSION 1 0.0000
871 PALPITATIONS 2 0.0000
872 SURGERY 1 0.0000
873 NO ADVERSE EVENT 3 0.0000
874 STOMATITIS 1 0.0000
875 FEELING HOT 1 0.0000
876 PAIN 10 0.0000
877 ASTHENIA 6 0.0000
878 DIARRHOEA 10 0.0000
879 HEPATIC ENZYME INCREASED 1 0.0000
880 PYREXIA 5 0.0000
881 DEVICE MALFUNCTION 1 0.0000
882 BRONCHITIS 1 0.0000
883 DYSGEUSIA 1 0.0000
884 ABDOMINAL PAIN 3 0.0000
885 PROSTATE CANCER 1 0.0000
886 THROMBOSIS 1 0.0000
887 TREATMENT FAILURE 1 0.0000
888 DRUG ABUSE 1 0.0000
889 ABDOMINAL DISCOMFORT 2 0.0000
890 CEREBROVASCULAR ACCIDENT 2 0.0000
891 COVID-19 2 0.0000
892 DRUG WITHDRAWAL SYNDROME 1 0.0000
893 GASTROINTESTINAL DISORDER 1 0.0000
894 ADVERSE EVENT 1 0.0000
895 WEIGHT DECREASED 3 0.0000
896 PULMONARY EMBOLISM 1 0.0000
897 MIGRAINE 1 0.0000
898 GAIT DISTURBANCE 2 0.0000
899 DEATH 9 0.0000
900 SYNCOPE 1 0.0000
901 FLUSHING 1 0.0000
902 CHEST DISCOMFORT 1 0.0000
903 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
904 ABDOMINAL PAIN UPPER 2 0.0000
905 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
906 ABDOMINAL DISTENSION 1 0.0000
907 PLATELET COUNT DECREASED 1 0.0000
908 FALL 3 0.0000
909 INFLUENZA 1 0.0000
910 NAUSEA 7 0.0000
911 DEPRESSION 2 0.0000
912 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
913 DECREASED APPETITE 2 0.0000
914 BACK PAIN 2 0.0000
915 VISUAL IMPAIRMENT 1 0.0000
916 HEADACHE 5 0.0000
917 VISION BLURRED 1 0.0000
918 MEMORY IMPAIRMENT 1 0.0000
919 INJECTION SITE PAIN 2 0.0000
920 DRUG DEPENDENCE 1 0.0000
921 DIZZINESS 3 0.0000
922 NASOPHARYNGITIS 1 0.0000
923 FATIGUE 4 0.0000
924 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
925 FEELING ABNORMAL 1 0.0000